Stuart M. Feinblatt has over thirty years of experience as a trial and appellate lawyer. He concentrates his practice on defending business entities in complex disputes in state and federal courts throughout the United States. Mr. Feinblatt has been active in the area of product liability litigation, particularly in cases brought against the pharmaceutical, medical device and consumer product industries. In these cases, he has played a leading role in all aspects of pre-trial, trial and appellate proceedings in several jurisdictions. Mr. Feinblatt has or is currently serving, with other members of the Firm, as national litigation defense counsel defending several mass torts, including diet drugs, hormone replacement therapy, generic acne medication and latex glove products liability litigation. Mr. Feinblatt has also been called upon by pharmaceutical and medical device companies to provide legal and regulatory advice. Mr. Feinblatt also has extensive experience in general commercial litigation matters involving several industries. He has represented several corporations defending class actions involving claims of consumer fraud and related allegations, among others. Mr. Feinblatt also has substantial experience in either seeking or defending against requests for preliminary and final injunctive relief. Mr. Feinblatt is a co-author of a handbook for trial lawyers on evidence objections and a comprehensive text on New Jersey Products Liability Law, co-authored by other partners in the Firm's Product Liability Practice Group. Mr. Feinblatt has authored or co-authored several articles for legal publications on a variety of legal subjects. He is a frequent lecturer on product liability issues affecting pharmaceutical and medical device companies. Mr. Feinblatt is currently Co-Chair of the ABA Mass Torts Class Action Subcommittee. Authored Articles 11/21/2011, Stuart M. Feinblatt - The End of Federal Injunctions of State Certification? 8/1/2011, Stuart M. Feinblatt - Stay Alert ! The Latest on "Innovator Liability" 8/1/2011, Stuart M. Feinblatt, Beth S. Rose and Gwen L. Coleman - Use of Social Networking Sites in Mass Tort Litigation: A Defense Perspective 4/1/2009, Jeffrey J. Greenbaum and Stuart M. Feinblatt - Hydrogen Peroxide: The Third Circuit's "Acid Test" For Class Certification 12/15/2008, Beth S. Rose and Stuart M. Feinblatt - The Relationship Between The Products Liability Act and The Consumer Fraud Act 10/27/2008, Stuart M. Feinblatt - State Products Liability Act: The FDA Rebuttable Presumption 2/19/2007, Stuart M. Feinblatt - Global Warming: A New Litigation Frontier 12/11/2006, Stuart M. Feinblatt - Judicial Activism In Failure-To-Warn Cases 3/20/2006, Stuart M. Feinblatt - Maintaining Control Relevant News 4/23/2007, Stuart M. Feinblatt - Taking On Climate Change Relevant Events 1/19/2011, Stuart M. Feinblatt - Recent Developments In Pharmaceutical Products Liability Litigation - A New Jersey Perspective 6/21/2007, Stuart M. Feinblatt - Judicial Symposium on Scientific Evidence in the Courts 10/25/2005, Beth S. Rose and Stuart M. Feinblatt - Drug and Medical Device Litigation 6/13/2005, Stuart M. Feinblatt - Minimizing Legal Risks in Drug Advertising and Promotion 3/1/2005, Stuart M. Feinblatt - Drug and Medical Device Litigation: The Corporate Counsel Guide to Minimizing Risk and Reducing Exposure 12/12/2004, Stuart M. Feinblatt - ACI's Drug & Medical Device Litigation Conference 6/21/2004, Stuart M. Feinblatt - Drug Advertising and Promotion |